With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.

The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

The differences in health-seeking behaviour in men and women, and how they access health services are affected by differences ...

Sutton recently became a certified menopause practitioner to better help her patients, and she prescribes hormone replacement ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

HRT is the use of the hormone therapy such as estrogen or progestins, or both, in managing symptoms of menopause. On November 10, 2025, the FDA announced the removal of the black box warning on ...

On Dec. 15, Sprout Pharmaceuticals received approval to use its pill, Addyi (flibanserin), to treat low sexual desire in ...

Scientists aren’t entirely sure what causes rosacea, or why it intensifies as you get older, but they have some theories.

Discover how menopause impacts heart health. Learn about the five signs of heart changes during menopause and ways to reduce ...

Perimenopause and menopause used to be dismissed simply as symptoms of getting older, but that’s shifting thanks to ...

Zoom in or out of the page as needed for optimal reading comfort. You can also use a pinch gesture to zoom on touch devices.